Get startedLog in
    Picture of SynAct Pharma AB logo

    SYNACT — SynAct Pharma AB News Story

    0.000.00%
    se flag iconLast trade - 00:00
    HealthcareHighly SpeculativeSmall CapMomentum Trap
    All News

    Brief: SynAct Pharma CEO And CSO Sell Shares

    Picture of SynAct Pharma AB logoSynAct Pharma AB
    03/09/2026 06:32
    BRIEF-SynAct Pharma CEO And CSO Sell Shares
    Sept 3 (Reuters) - SynAct Pharma AB SYNACT.ST:
    • CEO JEPPE ØVLESEN SELLS 150,000 SHARES AT SEK 17.8 PER SHARE VIA QUANTASS APS
    • JEPPE ØVLESEN HOLDS 229,422 SHARES AND 722,688 WARRANTS AFTER SALE
    • CSO THOMAS JONASSEN SELLS 350,000 SHARES AT SEK 17.8 PER SHARE VIA TJ BIOTEK APS
    • THOMAS JONASSEN HOLDS 2,195,320 SHARES AND 516,205 WARRANTS AFTER SALE
    Source text: ID:nMFN2p3mrg
    Further company coverage: SYNACT.ST

     (Gdansk Newsroom)
     ((gdansk.newsroom@thomsonreuters.com; +48 58 7696600;))

    Recent news on SynAct Pharma AB

    See all news